A message from our Chair

AHSNs have transformed the way the NHS identifies, adopts and spreads promising innovations.

In our first decade we have improved health outcomes and supported economic growth, both individually and working together as the AHSN Network.

Since 2018 our national initiatives have benefited more than 2.3 million patients, and our support to innovators has helped contribute more than £1.8bn to UK PLC, created or safeguarded more than 6,600 jobs, and delivered a return on investment of almost £3 for every pound.

As we begin our third five-year licence, now as Health Innovation Networks, I would like to thank all my colleagues from across the Network and partner organisations for their dedication and support. We will continue to champion and support scale-up of the best healthcare innovations to improve health, support the NHS, and achieve economic growth.

Professor Gary Ford CBE, FMedSci
Chair of the AHSN Network and Chief Executive of Oxford AHSN

 

The AHSN Network Impact Report 2022-23

 

Download the Impact Report.

 

2022-23 impacts

 

National impacts 2022-23 - More than 530,000 patients have benefitted from our national programmes and initiatives - More than 179,000 hours of healthcare staff capacity released across local and national initiatives - 5,488 interactions with companies - 565 jobs created and 763 jobs safeguarded in companies supported by AHSNs - 184 companies created long-term strategic partnerships - 1,512 innovations in our national pipeline of innovation - Almost £428m investment leveraged by companies supported by AHSNs - 2,831 companies supported

  • Polypharmacy Action Learning Set celebrates 1000th delegate

    Polypharmacy Action Learning Set celebrates 1000th delegate

    Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]

  • Meet the innovator: Jo Barosa, Qbtech

    Meet the innovator: Jo Barosa, Qbtech

    Jo Barosa is Account Director at Qbtech UK. Qbtech is a market leading provider of innovative objective tests for assessing and treating ADHD, changing the landscape of ADHD care. Driven by its mission to improve the lives of people with ADHD, Qbtech supports by providing digital and clinical solutions to improve clinical decision making, service [...]

  • Prevention may be the cure, but innovation the best course of treatment

    Prevention may be the cure, but innovation the best course of treatment

    Dr Cheryl Crocker, interim Chief Operating Officer at the Health Innovation Network, explains the vital role innovation plays to not only reduce waiting lists and improve access to care, but to decrease system pressure by improving people’s health and keeping them well for longer.  The new Government has rightly declared its focus on moving the [...]